GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » 12-1 Month Momentum %

Qilian International Holding Group (Qilian International Holding Group) 12-1 Month Momentum % : -40.01% (As of May. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-01), Qilian International Holding Group's 12-1 Month Momentum % is -40.01%.

The industry rank for Qilian International Holding Group's 12-1 Month Momentum % or its related term are showing as below:

QLI's 12-1 Month Momentum % is ranked worse than
82.66% of 1113 companies
in the Drug Manufacturers industry
Industry Median: -7.26 vs QLI: -40.01

Competitive Comparison of Qilian International Holding Group's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's 12-1 Month Momentum % falls into.



Qilian International Holding Group  (NAS:QLI) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Qilian International Holding Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines